Navigation Links
R&D Magazine Selects Xoft Axxent(R) Electronic Brachytherapy System as Editor's Choice Innovation Award Winner
Date:3/18/2009

Xoft Axxent(R) Miniature Brachytherapy X-ray Source Recognized

as Most Innovative New Product of the Year

SUNNYVALE, Calif., March 18 /PRNewswire/ -- Xoft, Inc. today announced that R&D Magazine selected the Axxent(R) High Dose Rate (HDR) X-ray Source as Editor's Choice Most Innovative New Product of 2008. The award was announced at the recent R&D 100 Awards ceremony, where the Xoft system was recognized as one of the year's most technologically significant products. Established by the editors of R&D Magazine in 1963, the R&D 100 Awards are designed to recognize significant technological achievements and products that leapfrog current technology and that provide simple, elegant solutions to complex or long-standing technical or practical problems.

"Over the years, R&D Magazine has recognized innovation and impact from products and technologies that have gone on to become household names, such as the ATM, the fax machine, the Kodak photo CD, HDTV and the Nicoderm anti-smoking patch. Being recognized by the editors of this prestigious R&D Magazine as the most innovative new product is a tremendous honor," said Paul Lovoi PhD, CTO and co-founder of Xoft. "This further validates that the Axxent miniature X-ray source is a fundamentally new way to deliver therapeutic radiation - one that we believe is the enabling technology for many generations of increasingly more sophisticated, accurate, and accessible radiation treatment systems."

As a platform technology, the Axxent System addresses a variety of oncological and non-oncological indications. The Axxent System delivers non-radioactive therapy directly to cancer sites with minimal radiation exposure to surrounding healthy tissue. Designed to deliver electronic, X-ray-based radiation treatment, the proprietary Axxent treatment platform can be used in many clinical settings. Treatment can be performed without the need for a shielded room, allowing the radiation oncologist and other medical personnel to be present during treatment delivery and minimizing patient anxiety. As a result, tens of thousands of patients annually will have greater access to therapy that is delivered more easily and conveniently. Commercially available for treatment of early stage breast cancer, endometrial, skin and surface indications, the Axxent System is also cleared for use in the treatment of surface cancers or conditions where radiation therapy is indicated.

"We were pleased to have the Axxent System included in the R&D 100, but to be named by the editors as the most innovative new product of the year is a testament to the hard work and dedication of the entire Xoft organization to bring this critical cancer treatment to market," said Michael Klein, president and CEO of Xoft. "Combined with growing utilization of Electronic Brachytherapy for the treatment of breast and endometrial cancers, this continues to validate the paradigm shifting capabilities of this innovative technology."

To learn more about the R&D 100 Awards, visit www.RDmag.com.

About Xoft, Inc.

Xoft, founded in 1998, develops Electronic Brachytherapy (eBx) systems based upon miniaturized X-ray tube technology for the practice of radiation oncology in virtually any clinical setting, eliminating the need for heavily shielded environments. Xoft provides a "point of care model" that is patient centric and accessible to a broader spectrum of patients and their physicians. The Axxent treatment platform provides a therapeutic dose of radiation directly to the region at risk with minimal radiation exposure to surrounding healthy tissue and without the complex handling, resource logistics and costs associated with using radioactive isotopes. Xoft aligns with the Nuclear Regulatory Commission's (NRC) directive to seek alternatives for radioactive medical isotopes. Commercially available for treatment of early stage breast cancer, endometrial, skin and surface indications, the Axxent(R) Electronic Brachytherapy System is also cleared for use in the treatment of other cancers or conditions where radiation therapy is indicated. For more information, visit www.xoftinc.com.

Axxent is a registered trademark of Xoft, Inc.


'/>"/>
SOURCE Xoft, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. BD Named to 100 Best Corporate Citizens List by CRO Magazine
2. Scientology Magazine Earns Religion Communicators Council Award
3. SOBeFiT Magazine Wins Best Magazine Launch Party at 2009 FAME Awards
4. Quest Diagnostics Again Named to FORTUNE Magazines Worlds Most Admired Companies List
5. FORTUNE Magazine Ranks DaVita #1 Health Care Medical Facility in Innovation, Investment and Quality
6. The National Association of People with AIDS (NAPWA) and POZ Magazine Partner to Launch The Denver Principles Project
7. Lindt & Sprungli and Cookie Magazine Team up to Honor Lindt Unsung Heroes of Autism
8. Solos Endoscopy, Inc.s Breast Endoscopy System Featured in January Issue of Outpatient Surgery Magazine
9. How to Stay Healthy on a Budget: 31 Money-saving Tips From Natural Solutions Magazine
10. Solos Endoscopy, Inc.s MammoView(TM) Featured in December Issue of Surgical Products Magazine
11. Samplify Systems SAM1600 Family of Analog/Digital Converters Named Finalist in EDN Magazines 19th Annual Innovation Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 2016 , ... Comfort Keepers® of San Diego, CA is excited to announce ... program to drive cancer patients to and from their cancer treatments. Comfort Keepers ... of life and ongoing independence. Getting to and from medical treatments is one ...
(Date:6/24/2016)... ... 2016 , ... People across the U.S. are sharpening their pencils and honing ... contest in which patients and their families pay tribute to a genetic counselor by ... Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
(Date:6/24/2016)... Maryland (PRWEB) , ... June 24, 2016 , ... ... Angels is actively feeding the Frederick area economy by obtaining investment capital for ... over the past 2½ years that have already resulted in more than a ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) sponsors ... on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, ... to helping service members that have been wounded in battle and their families. Venture ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
Breaking Medicine Technology: